2021
DOI: 10.1007/s11010-021-04200-7
|View full text |Cite
|
Sign up to set email alerts
|

Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment

Abstract: Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide and resulted in more than 3.5 million deaths so far. The infection causes Coronavirus disease in people of all age groups, notably diabetic and old age people, at a higher risk of infectivity and fatality. Around 35% of the patients who have died of the disease were diabetic. The infection is associated with weakening immune response, chronic inflammation, and potential direct pancreatic impairment. There seems to be a t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 75 publications
0
11
0
Order By: Relevance
“…Another promising molecule, DPP-4 antagonist (Linagliptin), an anti-diabetic agent with potential anti-aging properties, was repurposed to combat COVID-19 infection also demonstrates antiaging properties. Further, plant-based natural compounds such as resveratrol, catechin, curcumin, procyanidin, and theaflavin have been tested for the treatment of COVID-19 disease through in silico , in vitro , and in vivo studies . More recently, convalescent plasma therapy has also been applied for COVID-19 associated comorbidities wherein it was used to downregulate the inflammatory cytokines and the viral load in COVID-19 patients .…”
Section: Covid-19 and Comorbiditiesmentioning
confidence: 99%
“…Another promising molecule, DPP-4 antagonist (Linagliptin), an anti-diabetic agent with potential anti-aging properties, was repurposed to combat COVID-19 infection also demonstrates antiaging properties. Further, plant-based natural compounds such as resveratrol, catechin, curcumin, procyanidin, and theaflavin have been tested for the treatment of COVID-19 disease through in silico , in vitro , and in vivo studies . More recently, convalescent plasma therapy has also been applied for COVID-19 associated comorbidities wherein it was used to downregulate the inflammatory cytokines and the viral load in COVID-19 patients .…”
Section: Covid-19 and Comorbiditiesmentioning
confidence: 99%
“…The HawkDock server has been used to understand proteinprotein interactions in various different processes. [69,70,71] Our studies indicate that Shoc2 dimerization is likely to happen when HECT binds to Shoc2. Further studies need to be conducted to understand the details on this mechanism.…”
Section: Control Of Shoc2 Activity By Various Binding Partnersmentioning
confidence: 72%
“…The program uses ATTRACT algorithm and Molecular mechanics with generalised Born and surface area solvation (MM/GBSA) simulations to determine the protein‐protein binding affinities. The HawkDock server has been used to understand protein–protein interactions in various different processes [69,70,71] . Our studies indicate that Shoc2 dimerization is likely to happen when HECT binds to Shoc2.…”
Section: Control Of Shoc2 Activity By Various Binding Partnersmentioning
confidence: 91%
“…The intake of a plant-based diet was associated with 59% lower odds of moderate-to-severe COVID-19 severity [ 58 ] and a lower risk of COVID-19 infection [ 59 ]. The plant-based natural products used to cure patients infected with COVID-19 were reviewed [ 60 ]. Plants contain quercetin, and together with vitamin D and estradiol, they inhibit COVID-19 receptors, angiotensin-converting enzyme 2, etc.…”
Section: Resultsmentioning
confidence: 99%